Market revenue in 2023 | USD 7.9 million |
Market revenue in 2030 | USD 15.9 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 56.96% in 2023. Horizon Databook has segmented the Thailand real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The RWD is a crucial aspect of healthcare. Using RWE in decision-making offers several potential benefits, including reducing the cost & time required to source relevant information when population specific data is needed and when sufficient local evidence is lacking from available trials.
RWE also fills the information gap in the absence of clinical trials when it is not feasible or ethical to conduct a trial or when there is a significant unmet need. The extraction and analysis of RWD through observational studies or pragmatic trials are known as RWE and are used in Thailand's healthcare decision-making.
The use of RWE ranges from market authorization and coverage decisions of medical products to impact evaluation. As more data and information become available on using RWE, new processes & global standards are expected to emerge in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account